TopoTarget is a research-based biotechnology company focused on developing and marketing novel pharmaceuticals and identifying new indications for already existing compounds. The company develops and markets effective cancer therapeutics and maintains a broad pipeline of new cancer drug candidates. TopoTarget has discovered a new principle for improving cancer therapy that is based on catalytic inhibitors (CIs) of DNA topoisomerase.